Andere Sprachen Theracryf Plc

Aktien

A142UC

GB00BSVYN304

EVG

Verzögert London S.E. Andere Börsenplätze 09:48:10 17.05.2024			% 5 Tage	% 1. Jan.
0.72 ^GBX	-4.00%		-4.00%	-55.00%

26.04.	Evgen Pharma plc wird sein Börsenkürzel von EVG in TCF ändern	CI
04.04.	Evgen Pharma schließt Einzelhandelsangebot von Aktien ab	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Evgen Pharma plc will Change its Ticker to TCF from EVG	26.04.
Evgen Pharma plc will Change its Name to TheraCryf plc	26.04.
Norcros sells Johnson Tiles UK; Trifast trading well	25.04.
Northcoders launches bootcamp; Schroder invests	04.04.
Evgen Pharma Concludes Retail Offer of Shares	04.04.
Evgen Pharma plc - Retail Offer	20.03.
Evgen Pharma plc - Acquisition, Fundraising and Change of Name	20.03.
Evgen Pharma Signs Takeover Deal with Chronos Therapeutics; Raises Capital Via Share Issue, Subscription	20.03.
EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat	19.03.
Evgen Pharma plc agreed to acquire Chronos Therapeutics Ltd. from group of shareholders for £3.4 million.	19.03.
Evgen Pharma finds evidence of SFX-01 activity in colon cancer models	27.02.
Evgen Pharma plc Announces That the Laboratories of Professor Grace Chen, Associate Professor Justin Colacino, and Professor Duxin Sun At the University of Michigan, Usa Have Observed Activity of Sfx-01 in Models of Colon Cancer	27.02.
Evgen Pharma plc - Positive update on SFX-01 in vitro Glioblastoma studies	20.02.
Evgen Pharma shares up on studies into SFX-01 product progressing well	19.02.
Evgen Pharma plc Announces That the Laboratory of Dr Marjolein Geurts, Neuro-Oncologist At the Erasmus University Medical Centre Has Observed Continuing Activity of Sfx-01 in Gbm Cells	19.02.
Apax opts against lifting offer; DCI enters loan deal	09.02.
FTSE 100 falls at end of tepid week	09.02.
Evgen Pharma Issues Notice of Dispute to Stalicla Over Missed Milestone Payment	09.02.
Evgen partner raises USD17.4 million to support pipeline	16.01.
Evgen Pharma plc announced that it has received $17.4 million in funding from Stalicla SA	16.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Theracryf Plc

Aktien

A142UC

GB00BSVYN304

EVG

Andere Sprachen

Filter